Clinical Trial Update: Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer

View source ↗

Summary

Update on a Wake Forest University Health Sciences trial evaluating tamoxifen resistance in women with Stage I, II, IIIA, or IIIB breast cancer; the study has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer | Status: TERMINATED